KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Inventory (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 13 years of Change in Inventory data on record, last reported at -$926000.0 in Q4 2025.

  • For Q4 2025, Change in Inventory fell 118.36% year-over-year to -$926000.0; the TTM value through Dec 2025 reached $13.7 million, up 169.65%, while the annual FY2025 figure was $13.7 million, 169.65% up from the prior year.
  • Change in Inventory reached -$926000.0 in Q4 2025 per IONS's latest filing, down from $2.1 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $13.5 million in Q2 2025 and bottomed at -$4.2 million in Q2 2022.
  • Average Change in Inventory over 5 years is $936450.0, with a median of $131500.0 recorded in 2023.
  • Peak YoY movement for Change in Inventory: plummeted 430.77% in 2022, then soared 1590.72% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $1.9 million in 2021, then tumbled by 162.1% to -$1.2 million in 2022, then increased by 2.83% to -$1.1 million in 2023, then surged by 545.58% to $5.0 million in 2024, then tumbled by 118.36% to -$926000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$926000.0 in Q4 2025, $2.1 million in Q3 2025, and $13.5 million in Q2 2025.